By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Fibrocell Science, Inc. 

405 Eagleview Boulevard

Exton  Pennsylvania  19341  U.S.A.
Phone: 484-713-6000 Fax: 484-713-6001


SEARCH JOBS


Industry
Biotechnology






Company News
Fibrocell Science, Inc. Takes Active Role To Support Dystrophic Epidermolysis Bullosa Patient Advocacy Group 7/23/2014 1:07:40 PM
Fibrocell Science, Inc. Announces Exclusive Technology License Agreements With University of California, Los Angeles (UCLA) To Advance The Development Of Personalized Cell Therapies 6/17/2014 10:03:41 AM
Fibrocell Science, Inc. Receives Orphan Drug Designation For Genetically-Modified Autologous Human Fibroblasts To Advance Treatment Development for Recessive Dystrophic Epidermolysis Bullosa (RDEB) 6/13/2014 7:53:39 AM
Fibrocell Science, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 8:01:56 AM
Fibrocell Science, Inc. Announces Plans For Process Development And Manufacturing Of Genetically-Modified Cell Therapy For Rare Disease, RDEB 5/28/2014 10:03:41 AM
Fibrocell Science, Inc. Reports First Quarter 2014 Financial And Operating Results 5/20/2014 6:45:43 AM
Fibrocell Science, Inc. To Report First Quarter 2014 Financial And Operating Results, And Host Conference Call And Webcast On May 19, 2014 5/16/2014 6:54:25 AM
Fibrocell Science, Inc. Announces Delay In Filing Quarterly Report On Form 10Q 5/13/2014 7:13:53 AM
Fibrocell Science, Inc. To Present At 2nd Annual Regen Med Investor Day And BioCentury Future Leaders In The Biotech Industry Conference 3/21/2014 6:27:26 AM
Fibrocell Science, Inc. Reports Fourth Quarter And Full Year 2013 Financial And Operating Results 3/17/2014 8:35:27 AM
123456789
//-->